ProMetic Life Sciences Inc.

TSX : PLI
OTCQX : PFSCF


ProMetic Life Sciences Inc.

March 21, 2014 12:53 ET

ProMetic to Report its Fourth Quarter and Year End 2013 Financial Results and Hold Conference Call/Webcast

LAVAL, QUEBEC--(Marketwired - March 21, 2014) - ProMetic Life Sciences Inc. (TSX:PLI)(OTCQX:PFSCF) ("ProMetic" or the "Corporation") today announced that it will report its financial results for the fourth quarter and fiscal year ended December 31, 2013 on Wednesday March 26, 2014 after market trading hours.

ProMetic will host a conference call at 11:00am (ET) on Thursday, March 27, 2014. The telephone numbers to access the conference call are 647-788-4922 (International) and 1-877-223-4471 (North America Toll-Free). A live audio webcast of the conference call will be available via http: http://www.gowebcasting.com/5345

An audio replay of the call will be available as of Thursday March 27, 2014, at 2:00pm (E T). The numbers to access the audio replay are (416) 621-4642 (international) and 1 (800) 585-8367 (North America Toll Free) using access code: 17917398.

About ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc. (www.prometic.com) is a long established biopharmaceutical company with globally recognized expertise in bioseparations, plasma-derived therapeutics and small-molecule drug development. ProMetic offers its state of the art technologies for large-scale purification of biologics, drug development, proteomics and the elimination of pathogens to a growing base of industry leaders and uses its own affinity technology that provides for highly efficient extraction and purification of therapeutic proteins from human plasma in order tto develop best-in-class therapeutics. ProMetic is also active in developing its own novel small-molecule therapeutic products targeting unmet medical needs in the field of fibrosis, anemia, neutropenia, cancer and autoimmune diseases/inflammation as well as certain nephropathies Headquartered in Laval (Canada), ProMetic has R&D facilities in the UK, the U.S. and Canada, manufacturing facilities in the UK and business development activities in the U.S., Europe and Asia.

Contact Information

  • Pierre Laurin
    President and CEO
    ProMetic Life Sciences Inc.
    p.laurin@prometic.com
    +1.450.781.0115

    Frederic Dumais
    Director, Communications and
    Investor Relations
    ProMetic Life Sciences
    f.dumais@prometic.com
    +1.450.781.0115